GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Egr1 | rn6_v1_chr18_+_27657628_27657628 | 0.37 | 6.4e-12 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_22211071 Show fit | 69.15 |
ENSRNOT00000087817
ENSRNOT00000001910 |
actin-like 6B |
|
chr14_-_86297623 Show fit | 57.92 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
calcium/calmodulin-dependent protein kinase II beta |
|
chr11_+_86512797 Show fit | 55.44 |
ENSRNOT00000051680
|
glycoprotein Ib platelet beta subunit |
|
chr8_+_22050222 Show fit | 53.53 |
ENSRNOT00000028096
|
intercellular adhesion molecule 5 |
|
chr1_-_103256823 Show fit | 48.86 |
ENSRNOT00000018860
|
protein tyrosine phosphatase, non-receptor type 5 |
|
chr3_+_155103150 Show fit | 48.78 |
ENSRNOT00000020720
|
solute carrier family 32 member 1 |
|
chr1_+_144070754 Show fit | 48.13 |
ENSRNOT00000079989
|
SH3 domain-containing GRB2-like 3 |
|
chr12_-_22680630 Show fit | 46.49 |
ENSRNOT00000041808
|
VGF nerve growth factor inducible |
|
chr7_-_119768082 Show fit | 46.15 |
ENSRNOT00000009612
|
somatostatin receptor 3 |
|
chrX_+_157150655 Show fit | 45.21 |
ENSRNOT00000090795
|
pregnancy up-regulated nonubiquitous CaM kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 70.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
7.6 | 61.1 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
19.3 | 57.9 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
11.1 | 55.3 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
3.7 | 52.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 51.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
8.1 | 48.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
5.4 | 48.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.4 | 46.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
7.7 | 46.1 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 164.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.8 | 81.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.3 | 72.5 | GO:0060170 | ciliary membrane(GO:0060170) |
4.8 | 66.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.4 | 66.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.8 | 57.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
1.9 | 53.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.4 | 48.9 | GO:1990635 | proximal dendrite(GO:1990635) |
9.8 | 48.8 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 48.1 | GO:0031901 | early endosome membrane(GO:0031901) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 99.5 | GO:0043274 | phospholipase binding(GO:0043274) |
1.6 | 83.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.8 | 78.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.4 | 57.0 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.4 | 53.5 | GO:0005178 | integrin binding(GO:0005178) |
0.7 | 52.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.1 | 48.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
9.8 | 48.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
1.5 | 46.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
7.7 | 46.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 86.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
2.2 | 57.9 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.0 | 36.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
1.7 | 35.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
1.2 | 34.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.7 | 28.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.5 | 28.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.0 | 27.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 24.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 18.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 96.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
5.4 | 96.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 80.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
4.1 | 61.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.7 | 55.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
3.5 | 52.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
3.4 | 40.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.9 | 36.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.4 | 36.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 36.1 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |